58
https://pubmed.ncbi.nlm.nih.gov/38116593
A patient with an aggressive, treatment-refractory form of MOGAD was successfully treated with autologous hematopoietic stem cell transplantation (aHSCT), experiencing no disease activity for over 2 years.